Exagen Inc.
General ticker "XGN" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $130.5M (TTM average)
Exagen Inc. follows the US Stock Market performance with the rate: 23.7%.
Estimated limits based on current volatility of 4.7%: low 7.96$, high 8.76$
Factors to consider:
- Total employees count: 220 (+5.3%) as of 2025
- Top business risk factors: Operational and conduct risks, Payor coverage and pricing risks, Regulatory and compliance, Strategic risks and growth management, Facility damage
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.52$, 9.80$]
- 2026-12-31 to 2027-12-31 estimated range: [3.78$, 8.46$]
Financial Metrics affecting the XGN estimates:
- Positive: with PPE of -7.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of 0.30 <= 0.41
- Positive: -1.23 < Investing cash flow per share per price, % of -0.47
- Positive: Interest expense per share per price, % of 3.24 <= 4.56
- Negative: 0.12 < Industry inventory ratio change (median), % of 0.16
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -25.59
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -5.72
Short-term XGN quotes
Long-term XGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $52.55MM | $55.64MM | $66.58MM |
| Operating Expenses | $75.39MM | $69.28MM | $80.64MM |
| Operating Income | $-22.84MM | $-13.64MM | $-14.07MM |
| Non-Operating Income | $-0.82MM | $-1.47MM | $-5.83MM |
| Interest Expense | $2.33MM | $2.23MM | $4.32MM |
| R&D Expense | $4.87MM | $5.38MM | $6.25MM |
| Income(Loss) | $-23.66MM | $-15.10MM | $-19.90MM |
| Taxes | $0.03MM | $0.01MM | $0.05MM |
| Net Income(Loss)* | $-23.69MM | $-15.12MM | $-19.95MM |
| Stockholders Equity | $22.69MM | $9.54MM | $17.45MM |
| Assets | $56.94MM | $44.69MM | $58.02MM |
| Operating Cash Flow | $-14.46MM | $-13.28MM | $-13.62MM |
| Capital expenditure | $0.83MM | $0.52MM | $0.64MM |
| Investing Cash Flow | $-0.80MM | $-0.52MM | $-0.63MM |
| Financing Cash Flow | $-10.63MM | $-0.66MM | $24.43MM |
| Earnings Per Share** | $-1.34 | $-0.83 | $-0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.